🇺🇸 FDA
Patent

US 11965022

Methods and compositions for modulating CAR-T activity

granted A61KA61K2039/505A61K2039/804

Quick answer

US patent 11965022 (Methods and compositions for modulating CAR-T activity) held by Sana Biotechnology, Inc. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sana Biotechnology, Inc.
Grant date
Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K2039/804, A61K2239/31, A61K2239/38